Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
ZYME
-90.58%
▲ 0.54%
SYRE
-100.00%
Gross Margin
ZYME
100.00%
▲ 118.23%
SYRE
50.00%
▼ -50.00%
Free Cash Flow
ZYME
-$31.95M
▲ $13.77M
SYRE
-$69.88M
▼ -$12.51M
Net Debt / EBITDA
ZYME
0.01
▼ -3.67
SYRE
6.17
▲ 2.49
Operating Margin
ZYME
-918.95%
▲ 1037.77%
SYRE
-63.18%
▲ 23083.04%
P/E Ratio
ZYME
2.51
▼ -0.29
SYRE
—